Cytisine versus varenicline for smoking cessation for Māori (the indigenous people of New Zealand) and their extended family: protocol for a randomized non‐inferiority trial

BACKGROUND AND AIMS: Cytisine, a nicotinic acetylcholine receptor partial agonist (like varenicline) found in some plants, is a low‐cost, effective smoking cessation medication that may appeal to Māori [the indigenous people of New Zealand (NZ)]. The RAUORA trial aims to determine the effectiveness,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Addiction
Asıl Yazarlar: Walker, Natalie, Smith, Barry, Barnes, Joanne, Verbiest, Marjolein, Kurdziel, Tomasz, Parag, Varsha, Pokhrel, Subhash, Bullen, Chris
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2018
Konular:
Trial Protocol
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6587772/
https://ncbi.nlm.nih.gov/pubmed/30276931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/add.14449
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller